Comorbidity, Not Patient Age, is Associated with Impaired Safety Outcomes in Vedolizumab- and Ustekinumab-Treated Patients with Inflammatory Bowel Disease-a Prospective Multicentre Cohort Study.

Alimentary pharmacology & therapeutics(2020)

引用 26|浏览53
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要